ConnecticutDiabetes Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Diabetes are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Estimate Benchmark Distance to Benchmark
Short-stay home health patients who had diabetic foot care and patient education 97.7 98.6 0.9%
Adults age 40 and over with diagnosed diabetes who received a dilated eye examination in the calendar year 67.8 75.2 9.8%
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
Adults age 40 and over with diagnosed diabetes who received at least two hemoglobin A1c measurements in the calendar year 69.9 79.5 12.1%
Adults age 40 and over with diagnosed diabetes who had their feet checked for sores or irritation in the calendar year 73.2 84.0 12.9%
Adults age 40 and over with diagnosed diabetes who received a flu vaccination in the calendar year 55.6 65.8 15.6%
Measures With No Available Benchmark Information or Supplemental Measures
Measure Estimate Benchmark Distance to Benchmark
Patients with end stage renal disease due to diabetes 43.4
Patients 18 to 75 diagnosed with type I or type II diabetes with Hba1c 9% or lower 66.6